Development and validation of Agile 3+: novel FibroScan based score for the diagnosis of advanced fibrosis in patients with nonalcoholic fatty liver disease

被引：0

作者：

Younossi, Zobair ^{[1
]}

Harrison, Stephen ^{[2
]}

Newsome, Philip N. ^{[3
,4
,5
]}

Chan, Wah-Kheong ^{[6
]}

Yilmaz, Yusuf ^{[7
,8
]}

de Ledinghen, Victor ^{[9
]}

Costentin, Charlotte ^{[10
]}

Zheng, Ming-Hua ^{[11
]}

Wong, Vincent Wai-Sun ^{[12
]}

Elkhashab, Magdy ^{[13
]}

Huss, Ryan ^{[14
]}

Myers, Robert ^{[14
]}

Foucquier, Julie ^{[15
]}

Aymeric, Labourdette ^{[15
]}

Destro, Marie ^{[15
]}

Fournier, Celine ^{[15
]}

Miette, Veronique ^{[15
]}

Sandrin, Laurent ^{[15
]}

Boursier, Jerome ^{[16
,17
]}

Sanyal, Arun ^{[18
,19
]}

机构：

[1] Inova Hlth Syst, Inova Med, Falls Church, VA USA

[2] Univ Oxford, Radcliffe Dept Med, Oxford, England

[3] Birmingham Univ Hosp, Natl Inst Hlth Res Biomed Res Ctr, Birmingham, W Midlands, England

[4] Univ Birmingham, Inst Immunol & Immunotherapy, Ctr Liver & Gastrointestinal Res, Birmingham, W Midlands, England

[5] Univ Hosp Birmingham NHS Fdn Trust, Liver Unit, Birmingham, W Midlands, England

[6] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia

[7] Marmara Univ, Inst Gastroenterol, Liver Res Unit, Istanbul, Turkey

[8] Marmara Univ, Sch Med, Dept Gastroenterol, Istanbul, Turkey

[9] Haut Leveque Hosp, Hepatol Gastroenterol & Digest Oncol, Pessac, France

[10] Grenoble Alpes Univ Hosp, Hepatol Gastroenterol & Digest Oncol, Grenoble, France

[11] Wenzhou Med Univ, Affiliated Hosp 1, NAFLD Res Ctr, Dept Hepatol, Wenzhou, Peoples R China

[12] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China

[13] Toronto Liver Ctr, Toronto, ON, Canada

[14] Gilead Sci, Forster City, CA USA

[15] Echosens, Paris, France

[16] Angers Univ Hosp, Hepatogastroenterol & Digest Oncol Dept, Angers, France

[17] Angers Univ Hosp, HIFIH UPRES EA3859 Lab, Angers, France

[18] VCU Hlth Syst, Richmond, VA USA

[19] NIDDK, NASH Clin Res Network, NIH, Bethesda, MD 26506 USA

来源：

JOURNAL OF HEPATOLOGY | 2021年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OS-555

引用

页码：S257 / S257

页数：1

共 50 条

[1] Utility of Novel FibroScan-Based Scores in the Diagnosis of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
Romero, Ana
Romero, Jesus
Nguyen, Natalie
Oniyide, Oluseye
Sanchez, Javier
Egwim, Chukwuma
Ankoma-Sey, Victor
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1186 - S1186
[2] Independent validation of Agile 4: novel FibroScan based score for the diagnosis of cirrhosis in patients with non-alcoholic fatty liver disease
Boursier, Jerome
Roux, Marine
Costentin, Charlotte
Delamarre, Adele
Canivet, Clemence M.
Sturm, Nathalie
de Ledinghen, Victor
JOURNAL OF HEPATOLOGY, 2021, 75 : S565 - S565
[3] Reply: AGILE 3+score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease
Lombardi, Rosa
Dalbeni, Andrea
Mantovani, Alessandro
Ravaioli, Federico
HEPATOLOGY, 2024, 79 (06) : E155 - E156
[4] Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
Kao, Wei-Yu
Chang, I-Wei
Chen, Chi-Long
Su, Chien-Wei
Fang, Sheng Uei
Tang, Jui-Hsiang
Chang, Chun-Chao
Chang, Yu-Jia
Wang, Weu
OBESITY SURGERY, 2020, 30 (04) : 1249 - 1257
[5] Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
Wei-Yu Kao
I-Wei Chang
Chi-Long Chen
Chien-Wei Su
Sheng Uei Fang
Jui-Hsiang Tang
Chun-Chao Chang
Yu-Jia Chang
Weu Wang
Obesity Surgery, 2020, 30 : 1249 - 1257
[6] Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver disease
Oeda, Satoshi
Seko, Yuya
Hayashi, Hideki
Arai, Taeang
Iwaki, Michihiro
Yoneda, Masato
Shima, Toshihide
Notsumata, Kazuo
Ikegami, Tadashi
Fujii, Hideki
Toyoda, Hidenori
Miura, Kouichi
Morishita, Asahiro
Kawata, Kazuhito
Tomita, Kengo
Kawanaka, Miwa
Isoda, Hiroshi
Yamaguchi, Kanji
Fukushima, Hideaki
Kamada, Yoshihiro
Sumida, Yoshio
Aishima, Shinichi
Itoh, Yoshito
Okanoue, Takeshi
Nakajima, Atsushi
Takahashi, Hirokazu
Japan Study Grp Nonalcohol Fatty Liver Dis JSG NAFLD
HEPATOLOGY RESEARCH, 2023, 53 (06) : 489 - 496
[7] DISCORDANCY IN FIBROSIS SCORE ON FIBROSCAN COMPARED WITH LIVER BIOPSY AND ITS RELATIONSHIP TO FATTY LIVER DISEASE IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS
Mitchell, Brittany
Fahad, Hamna
Sarmini, Muhammad Talal
McCullough, Arthur
GASTROENTEROLOGY, 2020, 158 (06) : S1410 - S1411
[8] The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
Cichoz-Lach, Halina
Celinski, Krzysztof
Prozorow-Krol, Beata
Swatek, Jaroslaw
Slomka, Maria
Lach, Tomasz
MEDICAL SCIENCE MONITOR, 2012, 18 (12): : CR735 - CR740
[9] The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease study
Jafarov, Fuad
Kaya, Eda
Bakir, Alev
Eren, Fatih
Yilmaz, Yusuf
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (05) : 642 - 649
[10] Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan® to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Bertot, Luis C.
Jeffrey, Gary P.
de Boer, Bastiaan
Wang, Zhengyi
Huang, Yi
Garas, George
MacQuillan, Gerry
Wallace, Michael
Smith, Briohny W.
Adams, Leon A.
DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (06) : 2757 - 2767

← 1 2 3 4 5 →